Sarah Fortune on what’s next in the fight against tuberculosis
Sarah Fortune, our resident Tuberculosis expert on vaccines was on the panel of Combatting a global killer: What’s next in the fight against tuberculosis.
Category: Tuberculosis
Q&A with Qingyun Liu
With TB being such a multi-faceted disease, what aspect does your research focus on? My research is focused on understanding how Mycobacterium tuberculosis (M. tuberculosis) evolves to evade antibiotic killing in … Continue reading “Q&A with Qingyun Liu”
Q&A with Harim Won
With TB being such a multi-faceted disease, what aspect does your research focus on? My work focuses on how we can use a two-headed targeted degrader molecule to redirect Mtb’s … Continue reading “Q&A with Harim Won”
Failure of tuberculosis treatment linked to bacterial resilience
For immediate release: December 8, 2022 Boston, MA – Researchers have discovered a new form of altered drug susceptibility—dubbed antibiotic resilience—that enables Mycobacterium tuberculosis (Mtb) to survive antibiotic treatment. The study, led … Continue reading “Failure of tuberculosis treatment linked to bacterial resilience”
A better antibiotic for tuberculosis treatment
May 12, 2022 – Over the past few years of his PhD research, Harim Won has been laying the groundwork to develop a new type of antibiotic to treat tuberculosis (TB), … Continue reading “A better antibiotic for tuberculosis treatment”
A better antibiotic for tuberculosis treatment
Over the past few years of his PhD research, Harim Won has been laying the groundwork to develop a new type of antibiotic to treat tuberculosis (TB), addressing the long-standing … Continue reading “A better antibiotic for tuberculosis treatment”
The infectious disease that nobody ever thinks about
Before COVID, tuberculosis was the leading infectious disease killer in the world. To mark World TB Day, March 24, Sarah Fortune, John LaPorte Given Professor of Immunology and Infectious Diseases … Continue reading “The infectious disease that nobody ever thinks about”
